How I use maintenance therapy in acute myeloid leukemia
Treatment for patients with acute myeloid leukemia (AML) is being transformed for some patients, as targeted agents increase complete remission rates and s
Related Articles
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening
Key PointsT-PLL and other T-cell lymphomas are sensitive to drugs that target autophagy, nuclear export, and IAPs.IAP inhibition induces an upregulation of
FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells
Key PointsFLT3 gene is essential for ITD-mutated LSCs to establish and propagate leukemia, but not for FLT3–wild-type LSCs.Normal human HSCs do not require
Phase 1 trial of durvalumab (anti–PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma
Key PointsDurvalumab plus lenalidomide has an acceptable safety profile with durable responses in refractory/advanced CTCL in a phase 1 study.Immune checkp
Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data
Key PointsRecombinant ADAMTS13 can supply ADAMTS13 more efficiently than plasma to patients with congenital thrombotic thrombocytopenic purpura.Therapeutic
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma
Key PointsFavorable outcomes were observed with dose-dense induction and PET-driven consolidation, with 2-year PFS at 86.2% and OS at 93.2%.The interim PET
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation
Key PointsGlobal DNA methylation analysis reveals significant DMRs comparing WM with IgM-MGUS and IgM gammopathies with controls across genomic regions.Epi
How I manage major hemorrhage
Transfusions are part of standard care in many areas across medicine and are the “bread and butter” of practice for many hematologists, yet high-quality ev
Expanding the universe of T-PLL targets
In this issue of Blood, Pohly and colleagues present data from systematic, high-throughput drug screens for T-cell prolymphocytic leukemia (T-PLL), demonst
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
Key Points. Clonal hematopoiesis is present in at least 14% of patients with WM.Patients with CH are more likely to progress from IgM MGUS or…
In vitro studies of human erythropoiesis using a 3D silk-based bone marrow model that generates erythroblastic islands
Key Points3D silk-based bone marrow niches and flow chambers direct the generation of compartmentalized erythropoietic niches.Spatiotemporal control of ex